TVGN
Tevogen Bio Holdings Inc.Healthcare · $26M market cap
Verdict
We can't put a fair value on TVGN right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow TVGN
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Nov 2, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about TVGN
Are insiders buying TVGN?
Since Nov 2, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar).
How can I check TVGN's value myself?
Use the free Sticker Price calculator, already filled with TVGN's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Biotechnology
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Nov 4, 2026. How the Payback Price works